Search Results1-9 of  9

  • Nishiki Teiichi ID: 9000253166814

    Department of Veterinary Science, College of Agriculture, University of Osaka Prefecture (1990 from CiNii)

    Articles in CiNii:1

    • Immunochemical identification of the ADP-ribosyltransferase in botulinum C1 neurotoxin as C3 exoenzyme-like molecule. (1990)
  • Nishiki Teiichi ID: 9000258061671

    Department of Physiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (2009 from CiNii)

    Articles in CiNii:1

    • A CACNB4 mutation showing altered Ca<sub>v</sub>2.1 function in a patient with Dravet syndrome (2009)
  • Nishiki Teiichi ID: 9000261019449

    Articles in CiNii:1

    • Therapy for hyperthermia-induced seizures in Scn1a mutant rats (2011)
  • Nishiki Teiichi ID: 9000347072419

    Grad.Sch.Med.Univ.Okayama,Okayama,Japan (2007 from CiNii)

    Articles in CiNii:1

    • Development of bionanocapsules targeting to brain tumor (2007)
  • Nishiki Teiichi ID: 9000347073387

    Dept. of Physiology,Okayama Univ.of Grad.Sch. of Medicine,Dentisity and Pharmaceutical Sciences,Okayama,Japan (2007 from CiNii)

    Articles in CiNii:1

    • Molecular Mechanism of the regulation of Anti-Anxiety by Oxytocin (2007)
  • Nishiki Teiichi ID: 9000347075606

    Dept. of Physiology,Okayama Univ.of Grad.Sch. of Medicine,Dentisity and Pharmaceutical Sciences,Okayama,Japan (2008 from CiNii)

    Articles in CiNii:1

    • Molecular Mechanism of the regulation of Anti-Anxiety by Oxytocin (2008)
  • Nishiki Teiichi ID: 9000391607283

    Department of Veterinary Science, College of Agriculture, University of Osaka Prefecture (1990 from CiNii)

    Articles in CiNii:1

    • Immunochemical identification of the ADP-ribosyltransferase in botulinum C1 neurotoxin as C3 exoenzyme-like molecule. (1990)
  • Nishiki Teiichi ID: 9000405123731

    Articles in CiNii:1

    • CACNA1A variants may modify the epileptic phenotype of Dravet syndrome (2013)
  • Nishiki Teiichi ID: 9000405123763

    Articles in CiNii:1

    • Inhalation of 10% carbon dioxide rapidly terminates Scn1a mutation-related hyperthermia-induced seizures (2013)
Page Top